{"mainPropery":{"diseaseId":182,"diseaseName":"Best vitelliform macular dystrophy","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/182/best-vitelliform-macular-dystrophy","synonyms":["Best disease","Best macular dystrophy","Macular degeneration, polymorphic vitelline","Vitelliform macular dystrophy type 2","VMD2","BVMD","Early-onset vitelliform macular dystrophy","Juvenile-onset vitelliform macular dystrophy","Polymorphic vitelline macular degeneration"],"synonyms-with-source":[{"name":"Best disease"},{"name":"Best macular dystrophy"},{"name":"Macular degeneration, polymorphic vitelline"},{"name":"Vitelliform macular dystrophy type 2"},{"name":"VMD2"},{"name":"BVMD","source":"OrphaData.Org"},{"name":"Early-onset vitelliform macular dystrophy","source":"OrphaData.Org"},{"name":"Juvenile-onset vitelliform macular dystrophy","source":"OrphaData.Org"},{"name":"Polymorphic vitelline macular degeneration","source":"OrphaData.Org"}],"identifiers":[{"identifierType":"OMIM","identifierId":"153700"},{"identifierType":"ORPHANET","identifierId":"1243"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":9,"diseaseTypeName":"Eye diseases","source":"Orphanet"}],"organizations":[{"resourceID":109,"resourceName":"Prevent Blindness America","abbreviation":"","address1":"211 West Wacker Drive, Suite 1700","address2":"","address3":"","address4":"","address5":"","city":"Chicago","state":"IL","zip":"60606 ","country":"United States","phone":"","tty":"","tollFree":"800-331-2020","fax":"","email":"info@preventblindness.org","url":"http://www.preventblindness.org/","freeText":""},{"resourceID":110,"resourceName":"National Alliance for Eye and Vision Research ","abbreviation":"NAEVR","address1":"1801 Rockville Pike, Suite 400","address2":"","address3":"","address4":"","address5":"","city":"Rockville","state":"MD","zip":"20852","country":"United States","phone":"+1-240-221-2905","tty":"","tollFree":"","fax":"","email":"jamesj@eyeresearch.org","url":"https://www.eyeresearch.org/","freeText":""},{"resourceID":380,"resourceName":"Retina International","abbreviation":"","address1":"Suite 108, Camden Business Centre ","address2":"12 Camden Row","address3":"","address4":"","address5":"","city":"Dublin 8","state":"","zip":"","country":"Ireland","phone":"+353 1 472 0468","tty":"","tollFree":"","fax":"","email":"avril.daly@retina-International.org","url":"https://www.retina-international.org/","freeText":""},{"resourceID":199,"resourceName":"Foundation Fighting Blindness","abbreviation":"","address1":"7168 Columbia Gateway Drive, Suite 100","address2":"","address3":"","address4":"","address5":"","city":"Columbia","state":"MD","zip":"21046","country":"United States","phone":"+1-410-423-0600","tty":"1-800-683-5551","tollFree":"1-800-683-5555","fax":"","email":"info@fightblindness.org","url":"https://www.fightingblindness.org/","freeText":""},{"resourceID":715,"resourceName":"American Foundation for the Blind","abbreviation":"","address1":"1401 South Clark Street","address2":"Suite 730","address3":"","address4":"","address5":"","city":"Arlington","state":"VA","zip":"22202","country":"United States","phone":"212-502-7600","tty":"","tollFree":"800-232-5463","fax":"","email":"info@aph.org","url":"https://www.afb.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/153700' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=omim&cmd=Display&dopt=omim_pubmed_calculated&from_uid=153700' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Best vitelliform macular dystrophy. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='https://clinicaltrials.gov/ct2/results?term=Best+vitelliform+macular+dystrophy&Search=Search' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Best vitelliform macular dystrophy. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition=vitelliformmaculardystrophy' target='_blank'>MedlinePlus Genetics</a> contains information on Best vitelliform macular dystrophy. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":184,"resourceId":199,"resourceName":"Foundation Fighting Blindness","descriptionText":"The Foundation Fighting Blindness has a <a href='http://www.blindness.org/index.php?option=com_simplestforum&amp;view=postlist&amp;forumId=10&amp;Itemid=161 ' target='_blank'>message board for Best disease</a>.","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Social Networking Websites"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/315/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/1227128-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=1243' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=bvd' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1542,"resourceId":2170,"resourceName":"RePORTER","descriptionText":"The <a href='http://projectreporter.nih.gov/reporter.cfm' target='_blank'>Research Portfolio Online Reporting Tool (RePORT)</a> provides access to reports, data, and analyses of research activities at the National Institutes of Health (NIH), including information on NIH expenditures and the results of NIH-supported research.  Although these projects may not conduct studies on humans, you may want to contact the investigators to learn more. To search for studies, enter the disease name in the \"Text Search\" box.  Then click \"Submit Query\".","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1564,"resourceId":2180,"resourceName":"National Eye Institute","descriptionText":"The <a href='http://www.nei.nih.gov/' target='_blank'>National Eye Institute</a> (NEI) provides more information on this topic. You can reach them by calling 301-496-5248 or by E-mail at 2020@nei.nih.gov","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:153700' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2722,"resourceId":4053,"resourceName":"Patient Registry","descriptionText":"A registry supports research by collecting of information about patients that share something in common, such as being diagnosed with Best vitelliform macular dystrophy. The type of data collected can vary from registry to registry and is based on the goals and purpose of that registry. Some registries collect contact information while others collect more detailed medical information. <a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries</a>.<br />\r\n<br />\r\nRegistries for&nbsp;Best vitelliform macular dystrophy:<br />\r\n<a href='https://www.myretinatracker.org/' target='_blank'>My Retina Tracker®</a><br />&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":2374,"questionText":"What is&nbsp;Best vitelliform macular dystrophy?","answerText":"<strong>Best vitelliform macular dystrophy</strong> (BVMD) is a slowly progressive form of <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001000.htm\" target=\"_blank\">macular degeneration</a>. It usually begins in childhood or adolescence, but age of onset and severity of vision loss can vary. Affected people first have normal vision, followed by decreased central <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003396.htm\" target=\"_blank\">visual acuity</a> and distorted vision (metamorphopsia). Peripheral vision is not affected.[8276] BVMD is characterized by atrophy of the <a href=\"http://www.retinalmicroscopy.com/pigment.html\" target=\"_blank\">retinal pigment epithelium</a>&nbsp;(The retina is the back part of the eye that contains the specialized cells that respond to light, known as &nbsp;photoreceptors) and impaired central visual function.[8310]&nbsp;BVMD is usually inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> manner, but <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> inheritance has been reported. The condition is typically caused by <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>  in the <em><a href=\"http://ghr.nlm.nih.gov/gene/BEST1\" target=\"_blank\">BEST1</a></em> <a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a>; in a few cases the cause is unknown. Treatment is symptomatic and involves the use of low vision aids, and direct <a href=\"http://www.webmd.com/eye-health/lasik-laser-eye-surgery#1\" target=\"_blank\">laser treatment</a> or <a href=\"http://www.amd.org/photodynamic-therapy-pdt/\" target=\"_blank\">photodynamic therapy</a>.&nbsp;Newer treatment includes anti-VEGF agents (<a href=\"https://www.cancer.gov/about-cancer/treatment/drugs/bevacizumab\" target=\"_blank\">bevacizumab</a>) and <a href=\"http://university.envisionus.com/Visibility/Volume-9-Issue-3-4-Bittner\" target=\"_blank\">transcorneal electrical retinal stimulation</a>.[8276]<span style=\"font-size: 12pt;\"></span>","dateModified":"2016-10-13T00:00:00"},"basicQuestions":[{"questionId":2375,"questionText":"What&nbsp;causes&nbsp;Best vitelliform macular dystrophy?","answerText":"Best vitelliform macular dystrophy (BVMD) is caused by changes (<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in the <a class=\"link-dapple\" title=\"B E S T 1\" href=\"http://ghr.nlm.nih.gov/gene=best1\" target=\"_blank\"><span><em>BEST1</em></span></a> gene.[8276] This gene gives the body instructions for making a protein called bestrophin. Bestrophin acts as a channel that controls the movement of chloride ions within the retina. It is thought that mutations in the <em>BEST1</em> gene affect the shape of the channel and its ability to properly regulate the flow of chloride. However, it is unclear how exactly this relates to the specific features of BVMD.[8277]","dateModified":"2016-10-13T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":8276,"authors":"MacDonald IM & Lee T","articleTitle":"Best Vitelliform Macular Dystrophy","bookWebsiteJournalTitle":"GeneReviews","date":"December 12, 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1167/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":8277,"authors":"","articleTitle":"Vitelliform macular dystrophy","bookWebsiteJournalTitle":"Genetics Home Reference","date":"December, 2013","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/vitelliform-macular-dystrophy","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2377,"questionText":"How is Best vitelliform macular dystrophy inherited?","answerText":"Best vitelliform macular dystrophy (BVMD) is most commonly inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> manner, although a few cases with <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> inheritance have been reported.[8276]<br />\r\n<br />\r\nIn autosomal dominant inheritance, having one changed (mutated) copy of the responsible gene in each cell is enough to cause symptoms of the condition. When a person with an autosomal dominant condition has children, each child has a 50% (1 in 2) chance to inherit the mutated gene. Most people with BVMD have an affected parent, but some people have the condition as the result of a new mutation that occurred for the first time.[8276]<br />\r\n<br />\r\nAutosomal recessive inheritance means that a person must have a mutation in both copies of the responsible gene in each cell to be affected. The parents of an affected person usually each carry one mutated copy of the gene and are referred to as carriers. Carriers typically do not show signs or symptoms of the condition. When two carriers of an autosomal recessive condition have children, each child has a 25% (1 in 4) risk to have the condition, a 50% (1 in 2) risk to be a carrier like each of the parents, and a 25% chance to not have the condition <em>and</em> not be a carrier.","dateModified":"2016-10-13T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":8276,"authors":"MacDonald IM & Lee T","articleTitle":"Best Vitelliform Macular Dystrophy","bookWebsiteJournalTitle":"GeneReviews","date":"December 12, 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1167/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":8295,"questionText":"How is Best vitelliform macular dystrophy diagnosed?","answerText":"Best vitelliform macular dystrophy (BVMD) may be diagnosed based on the findings on an exam of the fundus (the interior surface of the eye opposite the lens); an <a href=\"http://www.merriam-webster.com/medlineplus/electrooculogram\" target=\"_blank\">electrooculogram</a> (EOG); and the family history. An eye exam may include other tests as well. A fundus exam may show a typical yellow yolk-like macular lesion. <br />\r\n<br />\r\nThe EOG, which reflects the retinal pigmentary epithelium function, is the most diagnostic test for evaluating vitelliform macular dystrophy. In the majority of the cases, a severe decrease occurs in light response, reflected by an Arden (light-peak/dark-trough) ratio of 1.1-1.5. (The normal Arden ratio is 1.8.) Carriers will also have an abnormal EOG result.<sup><a>&nbsp;</a></sup>No correlation exists between EOG result and disease stage, visual acuity, or patient age. EOG results are usually symmetric for both eyes.[1488]<br />\r\n<br />\r\nThe family history in affected people is often consistent with either <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> or <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> inheritance.[8276]<br />\r\n<br />\r\nGenetic testing may also be used to make a diagnosis of BVMD. A <em>BEST1</em> mutation is detected in about 96% of affected people who have an affected family member. In people with no family history of BVMD, the mutation detection rate ranges between 50-70%. A mutation in BEST1 gene is more probable when a vitelliform lesion is accompanied by a reduced Arden ratio on EOG testing.&nbsp;The exact type of genetic test ordered to confirm a diagnosis may depend on a person's ancestry, family history, and/or whether other eye disorders are also being considered.[8276]","dateModified":"2016-10-14T00:00:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":1488,"authors":"Altaweel M","articleTitle":"Best Disease","bookWebsiteJournalTitle":"Medscape Reference","date":"2016","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1227128","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":8276,"authors":"MacDonald IM & Lee T","articleTitle":"Best Vitelliform Macular Dystrophy","bookWebsiteJournalTitle":"GeneReviews","date":"December 12, 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1167/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2378,"questionText":"How might Best vitelliform macular dystrophy be treated?","answerText":"There is no specific treatment for Best vitelliform macular dystrophy (BVMD) at this time.[1486][1488] Low vision aids help affected people with significant loss of visual acuity.[1485] Laser photocoagulation,&nbsp;photodynamic therapy, and anti-VEGF (vascular endothelial growth factor) agents such as <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a607001.html\" target=\"_blank\">bevacizumab</a> have shown limited success in treating some of the secondary features of BVMD such as choroidal neovascularization (when abnormal blood vessels grow under the macula and retina).[1485][1486][1488]","dateModified":"2016-10-13T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":1485,"authors":"MacDonald IM, Lee T","articleTitle":"Best Vitelliform Macular Dystrophy","bookWebsiteJournalTitle":"GeneReviews","date":"2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=bvd","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1486,"authors":"Besch D, Zrenner E","articleTitle":"Best disease","bookWebsiteJournalTitle":"Orphanet","date":"2013","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=EN&Expert=1243","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1488,"authors":"Altaweel M","articleTitle":"Best Disease","bookWebsiteJournalTitle":"Medscape Reference","date":"2016","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1227128","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":50119,"abbreviatedInquiry":"I'm a 29 yr old male. I made an appointment with a retina specialist because lines appear to look wavy. My doctor said it looks like Best disease but he is not 100% sure. Can it be something else? Is their another illness that's similar to Best?","caseQuestions":[{"questionId":8295,"questionText":"How is Best vitelliform macular dystrophy diagnosed?","answerText":"Best vitelliform macular dystrophy (BVMD) may be diagnosed based on the findings on an exam of the fundus (the interior surface of the eye opposite the lens); an <a href=\"http://www.merriam-webster.com/medlineplus/electrooculogram\" target=\"_blank\">electrooculogram</a> (EOG); and the family history. An eye exam may include other tests as well. A fundus exam may show a typical yellow yolk-like macular lesion. <br />\r\n<br />\r\nThe EOG, which reflects the retinal pigmentary epithelium function, is the most diagnostic test for evaluating vitelliform macular dystrophy. In the majority of the cases, a severe decrease occurs in light response, reflected by an Arden (light-peak/dark-trough) ratio of 1.1-1.5. (The normal Arden ratio is 1.8.) Carriers will also have an abnormal EOG result.<sup><a>&nbsp;</a></sup>No correlation exists between EOG result and disease stage, visual acuity, or patient age. EOG results are usually symmetric for both eyes.[1488]<br />\r\n<br />\r\nThe family history in affected people is often consistent with either <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> or <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> inheritance.[8276]<br />\r\n<br />\r\nGenetic testing may also be used to make a diagnosis of BVMD. A <em>BEST1</em> mutation is detected in about 96% of affected people who have an affected family member. In people with no family history of BVMD, the mutation detection rate ranges between 50-70%. A mutation in BEST1 gene is more probable when a vitelliform lesion is accompanied by a reduced Arden ratio on EOG testing.&nbsp;The exact type of genetic test ordered to confirm a diagnosis may depend on a person's ancestry, family history, and/or whether other eye disorders are also being considered.[8276]","dateModified":"2016-10-14T00:00:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":1488,"authors":"Altaweel M","articleTitle":"Best Disease","bookWebsiteJournalTitle":"Medscape Reference","date":"2016","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1227128","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":8276,"authors":"MacDonald IM & Lee T","articleTitle":"Best Vitelliform Macular Dystrophy","bookWebsiteJournalTitle":"GeneReviews","date":"December 12, 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1167/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":8296,"questionText":"What conditions are similar to Best vitelliform macular dystrophy?","answerText":"Best vitelliform macular dystrophy (BVMD) is typically recognized by its distinct lesion in the macula, but there are a few diseases of the retina that may be confused with BVMD.[8276] They include:\r\n<ul>\r\n    <li><a href=\"http://rarediseases.info.nih.gov/gard/10909/vitelliform-macular-dystrophy-adult-onset/resources/1\" target=\"_blank\">Adult-onset vitelliform macular dystrophy</a> (AVMD). This form of vitelliform macular dystrophy affects mainly middle-aged people and is inherited in an autosomal dominant manner. The findings on a fundus exam can easily be mistaken for BVMD, but the electrooculogram (EOG) is normal or only slightly reduced in affected people. There is significant overlap of signs and symptoms between BVMD and AVMD.</li>\r\n</ul>\r\n<ul>\r\n    <li><a href=\"http://rarediseases.info.nih.gov/gard/10260/macular-degeneration/resources/1\" target=\"_blank\">Age-related macular degeneration</a> (AMD). This common disorder is characterized by drusen (yellow deposits under the retina); disruption of the pigmented layer of the retina (retinal pigment epithelium); and choroidal neovascularization (growth of new blood vessels in the choroid).</li>\r\n</ul>\r\n<ul>\r\n    <li><a href=\"http://www.macularsociety.org/OneStopCMS/Core/TemplateHandler.aspx?NRMODE=Published&amp;NRNODEGUID=%7b742482D4-6848-4E4A-90AD-CD6E6BEF0C5A%7d&amp;NRORIGINALURL=%2fabout-macular-conditions%2fDystrophies%2fBulls-eye&amp;NRCACHEHINT=NoModifyGuest\" target=\"_blank\">Bull's eye maculopathy</a>. This descriptive clinical diagnosis can be seen in people with <a href=\"http://rarediseases.info.nih.gov/gard/11897/cone-dystrophy/resources/1\" target=\"_blank\">cone dystrophy</a>, <a href=\"http://rarediseases.info.nih.gov/gard/10790/cone-rod-dystrophy/resources/1\" target=\"_blank\">cone-rod dystrophy</a>, <a href=\"http://rarediseases.info.nih.gov/gard/181/stargardt-disease/resources/1\" target=\"_blank\">Stargardt disease</a>, and other conditions of the macula.[8276]</li>\r\n</ul>\r\n<p>Other conditions that may be part of the differential diagnosis of BVMD include <a href=\"http://ghr.nlm.nih.gov/condition/autosomal-dominant-vitreoretinochoroidopathy\" target=\"_blank\">autosomal dominant vitreoretinochoroidopathy</a> and <a href=\"http://rarediseases.info.nih.gov/gard/5694/retinitis-pigmentosa/resources/1\" target=\"_blank\">retinitis pigmentosa</a>.[8310]</p>","dateModified":"2015-02-17T00:00:00","references":[{"referenceId":8276,"authors":"MacDonald IM & Lee T","articleTitle":"Best Vitelliform Macular Dystrophy","bookWebsiteJournalTitle":"GeneReviews","date":"December 12, 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1167/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":8310,"authors":"Ian MacDonald","articleTitle":"Best vitelliform macular dystrophy","bookWebsiteJournalTitle":"Orphanet","date":"December, 2013","volume":"","pages":"","url":"http://www.orpha.net/consor4.01/www/cgi-bin/OC_Exp.php?lng=EN&Expert=1243","authors2":"","placeOfPublication":"","publisher":""}]}]},{"caseId":32408,"abbreviatedInquiry":"My girlfriend has&nbsp;Best vitelliform macular dystrophy&nbsp;and I feel helpless because she tells me there is nothing anyone could do. Are there any clinical trials or research studies for this type of disease? Is there any treatment that can help? Also, can you go completely blind from this condition?","caseQuestions":[{"questionId":2378,"questionText":"How might Best vitelliform macular dystrophy be treated?","answerText":"There is no specific treatment for Best vitelliform macular dystrophy (BVMD) at this time.[1486][1488] Low vision aids help affected people with significant loss of visual acuity.[1485] Laser photocoagulation,&nbsp;photodynamic therapy, and anti-VEGF (vascular endothelial growth factor) agents such as <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a607001.html\" target=\"_blank\">bevacizumab</a> have shown limited success in treating some of the secondary features of BVMD such as choroidal neovascularization (when abnormal blood vessels grow under the macula and retina).[1485][1486][1488]","dateModified":"2016-10-13T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":1485,"authors":"MacDonald IM, Lee T","articleTitle":"Best Vitelliform Macular Dystrophy","bookWebsiteJournalTitle":"GeneReviews","date":"2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=bvd","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1486,"authors":"Besch D, Zrenner E","articleTitle":"Best disease","bookWebsiteJournalTitle":"Orphanet","date":"2013","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=EN&Expert=1243","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1488,"authors":"Altaweel M","articleTitle":"Best Disease","bookWebsiteJournalTitle":"Medscape Reference","date":"2016","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1227128","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":5397,"questionText":"Are there any clinical trials&nbsp;for&nbsp;Best vitelliform macular dystrophy?","answerText":"<p>The U.S. National Institutes of Health, through the National Library of Medicine, developed <a href=\"http://www.clinicaltrials.gov/\" target=_blank>ClinicalTrials.gov</a> to provide patients, family members, and members of the public with current information on clinical research studies. To find these trials, click on the link above and use \"Best vitelliform macular dystrophy\" as your search term. After you click on a study, review its \"eligibility\" criteria to determine its appropriateness. Use the study’s contact information to learn more. Check this site often for regular updates.</p>\r\n<p>You can also contact the Patient Recruitment and Public Liaison (PRPL) Office at the National Institutes of Health (NIH). We recommend calling the toll-free number listed below to speak with a specialist, who can help you determine if you are eligible for any clinical trials. If you are&nbsp;located outside the <?xml:namespace prefix = st1 ns = \"urn:schemas-microsoft-com:office:smarttags\" /><st1:country-region w:st=\"on\"><st1:place w:st=\"on\">United States</st1:place></st1:country-region>, and would like to be contacted via telephone, you will need to&nbsp;provide your telephone&nbsp;number in full, including area code&nbsp;and international&nbsp;dialing prefix.</p>\r\n<p>Patient Recruitment and <st1:PlaceName w:st=\"on\">Public</st1:PlaceName> <st1:PlaceName w:st=\"on\">Liaison</st1:PlaceName> <st1:PlaceName w:st=\"on\">Office</st1:PlaceName><br><st1:PlaceName w:st=\"on\">NIH</st1:PlaceName> <st1:PlaceName w:st=\"on\">Clinical</st1:PlaceName> <st1:PlaceType w:st=\"on\">Center</st1:PlaceType><br><st1:place w:st=\"on\"><st1:City w:st=\"on\">Bethesda</st1:City>, <st1:State w:st=\"on\">Maryland</st1:State> <st1:PostalCode w:st=\"on\">20892-2655</st1:PostalCode></st1:place><br>Toll-free: 800-411-1222<br>Fax: 301-480-9793<br>Email: <a href=\"mailto:prpl@mail.cc.nih.gov\">prpl@mail.cc.nih.gov</a><br>Web site:&nbsp; <a href=\"http://clinicalcenter.nih.gov/\" target=_blank>http://clinicalcenter.nih.gov/</a></p>","dateModified":"2013-01-17T12:57:00","references":[]},{"questionId":5399,"questionText":"What research is currently being done on Best vitelliform macular dystrophy?","answerText":"<p>You can find relevant articles on Best vitelliform macular dystrophy through <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/\" target=_blank>PubMed</a>, a searchable database of biomedical journal articles. Although not all of the articles are available for free online, most articles listed in PubMed have a summary available. To obtain the full article, contact a medical/university library or your local library for interlibrary loan. You can also order articles online through the publisher’s Web site. Using \"Best vitelliform macular dystrophy\" as your search term should help you locate articles. Use the advanced search feature to narrow your search results. Click <a href=\"http://www.ncbi.nlm.nih.gov/pubmed?term=Best%20vitelliform%20macular%20dystrophy%20\" target=_blank>here </a>to view a search. </p>\r\n<p>The National Library of Medicine (NLM) Web site has a page for locating libraries in your area that can provide direct access to these journals (print or online). The Web page also describes how you can get these articles through interlibrary loan and Loansome Doc (an NLM document-ordering service). You can access this page at the following link http://nnlm.gov/members/. You can also contact the NLM toll-free at 888-346-3656 to locate libraries in your area.</p>","dateModified":"2013-01-17T12:57:00","references":[]},{"questionId":5398,"questionText":"Can individuals with Best vitelliform macular dystrophy&nbsp;become completely blind?","answerText":"The severity of vision loss varies widely in individuals with Best vitelliform macular dystrophy. People with this&nbsp;condition often lose their central vision and their eyesight may become blurry or distorted.&nbsp; However, peripheral (side)&nbsp;vision&nbsp;and the ability to see at night usually remain unaffected.[4452][4453]","dateModified":"2011-10-11T17:59:00","references":[{"referenceId":4452,"authors":"Genetics Home Reference","articleTitle":"Vitelliform macular dystrophy","bookWebsiteJournalTitle":"Genetics Home Reference","date":"October 4, 2011","url":"http://ghr.nlm.nih.gov/condition/vitelliform-macular-dystrophy","dateAccessed":"2011-10-06T00:00:00"},{"referenceId":4453,"authors":"MacDonald I, Lee T","articleTitle":"Best Vitelliform Macular Dystrophy","bookWebsiteJournalTitle":"GeneReviews","date":"April 7, 2009","url":"http://www.ncbi.nlm.nih.gov/books/NBK1167/","dateAccessed":"2011-10-06T00:00:00"}]}]},{"caseId":27668,"abbreviatedInquiry":"My friend has Best disease in his right eye. His vision in this eye is quite stable, although he sees a black spot wherever he focuses. Will his vision remain the same or it can it&nbsp;deteriorate? Is there any way to improve his vision?&nbsp;What are the chances of his left eye also developing Best disease?&nbsp;","caseQuestions":[{"questionId":2374,"questionText":"What is&nbsp;Best vitelliform macular dystrophy?","answerText":"<strong>Best vitelliform macular dystrophy</strong> (BVMD) is a slowly progressive form of <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001000.htm\" target=\"_blank\">macular degeneration</a>. It usually begins in childhood or adolescence, but age of onset and severity of vision loss can vary. Affected people first have normal vision, followed by decreased central <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003396.htm\" target=\"_blank\">visual acuity</a> and distorted vision (metamorphopsia). Peripheral vision is not affected.[8276] BVMD is characterized by atrophy of the <a href=\"http://www.retinalmicroscopy.com/pigment.html\" target=\"_blank\">retinal pigment epithelium</a>&nbsp;(The retina is the back part of the eye that contains the specialized cells that respond to light, known as &nbsp;photoreceptors) and impaired central visual function.[8310]&nbsp;BVMD is usually inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> manner, but <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> inheritance has been reported. The condition is typically caused by <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>  in the <em><a href=\"http://ghr.nlm.nih.gov/gene/BEST1\" target=\"_blank\">BEST1</a></em> <a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a>; in a few cases the cause is unknown. Treatment is symptomatic and involves the use of low vision aids, and direct <a href=\"http://www.webmd.com/eye-health/lasik-laser-eye-surgery#1\" target=\"_blank\">laser treatment</a> or <a href=\"http://www.amd.org/photodynamic-therapy-pdt/\" target=\"_blank\">photodynamic therapy</a>.&nbsp;Newer treatment includes anti-VEGF agents (<a href=\"https://www.cancer.gov/about-cancer/treatment/drugs/bevacizumab\" target=\"_blank\">bevacizumab</a>) and <a href=\"http://university.envisionus.com/Visibility/Volume-9-Issue-3-4-Bittner\" target=\"_blank\">transcorneal electrical retinal stimulation</a>.[8276]<span style=\"font-size: 12pt;\"></span>","dateModified":"2016-10-13T00:00:00","references":[{"referenceId":1488,"authors":"Altaweel M","articleTitle":"Best Disease","bookWebsiteJournalTitle":"Medscape Reference","date":"2016","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1227128","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":8276,"authors":"MacDonald IM & Lee T","articleTitle":"Best Vitelliform Macular Dystrophy","bookWebsiteJournalTitle":"GeneReviews","date":"December 12, 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1167/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":8310,"authors":"Ian MacDonald","articleTitle":"Best vitelliform macular dystrophy","bookWebsiteJournalTitle":"Orphanet","date":"December, 2013","volume":"","pages":"","url":"http://www.orpha.net/consor4.01/www/cgi-bin/OC_Exp.php?lng=EN&Expert=1243","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2376,"questionText":"How does Best vitelliform macular dystrophy affect vision?","answerText":"Best vitelliform macular dystrophy affects the retina, the specialized light-sensitive tissue that lines the back of the eye. Specifically,&nbsp;it disrupts cells in a small area near the center of the retina called the macula. The macula is responsible for sharp central vision, which is needed for detailed tasks such as reading, driving, and recognizing faces.[1484]<br><br>Best vitelliform macular dystrophy causes a fatty yellow pigment (lipofuscin) to build up in cells underlying the macula.[1484] Over time, the abnormal accumulation of this substance can damage cells that are critical for clear central vision. As a result, people with this disorder often lose their central vision, and their eyesight may become blurry or distorted. Best vitelliform macular dystrophy typically does not affect side (peripheral) vision or the ability to see at night.[1484]<br><br>Studies have shown that most people with&nbsp;Best vitelliform macular dystrophy retain enough vision for reading and driving in at least one eye into adulthood&nbsp;(88% have 20/40 or better vision). Vision usually deteriorates slowly and does not become significant until after age 40.[1488]","dateModified":"2010-09-10T16:25:00","references":[{"referenceId":1484,"authors":"","articleTitle":"Vitelliform macular dystrophy","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"2008","url":"http://ghr.nlm.nih.gov/condition=vitelliformmaculardystrophy","dateAccessed":"2009-07-28T00:00:00"},{"referenceId":1485,"authors":"MacDonald IM, Lee T","articleTitle":"Best Vitelliform Macular Dystrophy","bookWebsiteJournalTitle":"GeneReviews","date":"2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=bvd","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1487,"authors":"","articleTitle":"Best disease","bookWebsiteJournalTitle":"National Center for Biotechnology Information (NCBI)","date":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK22187/","dateAccessed":"2009-07-29T00:00:00"},{"referenceId":1488,"authors":"Altaweel M","articleTitle":"Best Disease","bookWebsiteJournalTitle":"Medscape Reference","date":"2016","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1227128","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":3623,"questionText":"What are the chances of developing&nbsp;Best vitelliform macular dystrophy in both eyes?","answerText":"Various studies have shown that only about 4% of these individuals with Best vitelliform macular dystrophy develop vision less than 20/200 in the better eye.[1488]","dateModified":"2010-09-10T16:16:00","references":[{"referenceId":1488,"authors":"Altaweel M","articleTitle":"Best Disease","bookWebsiteJournalTitle":"Medscape Reference","date":"2016","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1227128","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2378,"questionText":"How might Best vitelliform macular dystrophy be treated?","answerText":"There is no specific treatment for Best vitelliform macular dystrophy (BVMD) at this time.[1486][1488] Low vision aids help affected people with significant loss of visual acuity.[1485] Laser photocoagulation,&nbsp;photodynamic therapy, and anti-VEGF (vascular endothelial growth factor) agents such as <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a607001.html\" target=\"_blank\">bevacizumab</a> have shown limited success in treating some of the secondary features of BVMD such as choroidal neovascularization (when abnormal blood vessels grow under the macula and retina).[1485][1486][1488]","dateModified":"2016-10-13T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":1485,"authors":"MacDonald IM, Lee T","articleTitle":"Best Vitelliform Macular Dystrophy","bookWebsiteJournalTitle":"GeneReviews","date":"2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=bvd","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1486,"authors":"Besch D, Zrenner E","articleTitle":"Best disease","bookWebsiteJournalTitle":"Orphanet","date":"2013","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=EN&Expert=1243","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1488,"authors":"Altaweel M","articleTitle":"Best Disease","bookWebsiteJournalTitle":"Medscape Reference","date":"2016","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1227128","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":14438,"phenoTypeName":"Cystoid macular degeneration","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":15275,"phenoTypeName":"Metamorphopsia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9141,"phenoTypeName":"Color vision defect","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3040,"phenoTypeName":"Choroideremia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9372,"phenoTypeName":"Visual field defect","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5621,"phenoTypeName":"Abnormal electroretinogram","percentRanges":"-"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":10584,"phenoTypeName":"Macular dystrophy","percentRanges":"-"},{"phenoTypeId":10515,"phenoTypeName":"Reduced visual acuity","percentRanges":"-"},{"phenoTypeId":8551,"phenoTypeName":"Subretinal fluid","percentRanges":"-"},{"phenoTypeId":5614,"phenoTypeName":"Visual impairment","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Best_vitelliform_macular_dystrophy"}